Price (delayed)
$43.24
Market cap
$2.53B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.82
Enterprise value
$2.38B
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of
There are no recent dividends present for TWST.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.